Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Stephen A, Brassell"'
Publikováno v:
Journal of Cancer, Vol 1, Iss 1, Pp 223-229 (2010)
Objective: Computed tomography and chest radiographs provide the standard imaging for staging, treatment, and surveillance of testicular germ cell neoplasms. Positron emission tomography has recently been utilized for staging, but is somewhat limited
Externí odkaz:
https://doaj.org/article/f8b45001d2a04ef68e0145cee0c06af8
Autor:
Sara Bass, Shiv Srivastava, Gyorgy Petrovics, Michael Dean, Kristine Jones, Hong Lou, Yongmei Chen, Stefan Ambs, Lisa Garland, Isabell A. Sesterhenn, Amina Ali, Jennifer Cullen, William D. Figg, Denise Young, William L. Dahut, Stephen A Brassell, Inger L. Rosner, Tiffany H. Dorsey, Lakshmi Ravindranath, Douglas K. Price, Doug Ross, Indu Kohaar
Publikováno v:
Prostate Cancer and Prostatic Diseases
Background: Germline mutations in BRCA2 have been linked to a higher risk of prostate cancer (PCa), and high frequency of BRCA1 and BRCA2 (BRCA1/2) gene alterations was recently reported in metastatic castration-resistant PCa specimens. Mutations in
Autor:
Jennifer Cullen, Stephen A. Brassell, Yongmei Chen, Christopher Porter, James L'Esperance, Timothy Brand, David G. McLeod
Publikováno v:
Prostate Cancer, Vol 2011 (2011)
Introduction. Concern regarding overtreatment of prostate cancer (CaP) is leading to increased attention on active surveillance (AS). This study examined CaP survivors on AS and compared secondary treatment patterns and overall survival by race/ethni
Externí odkaz:
https://doaj.org/article/bcac8bb97ead44beb202a63daf004144
Autor:
Inger L. Rosner, Joseph R. Sterbis, David G. McLeod, Adam R. Metwalli, James O. L’Esperance, Jennifer Cullen, Yongmei Chen, Timothy C. Brand, Stephen A. Brassell, Christopher R. Porter
Publikováno v:
Urologic Oncology: Seminars and Original Investigations. 32:761-768
Objectives In patients with a rising prostate-specific antigen (PSA) level during treatment with androgen deprivation therapy, identification of men who progress to bone metastasis and death remains problematic. Accurate risk stratification models ar
Publikováno v:
Urologic Oncology: Seminars and Original Investigations. 31:1504-1510
Objective To determine the health-related quality of life (HRQoL) impact of prostate cancer interventions at 2 years post-treatment, and between the 12- and 24-month interval, to better characterize this measure. Materials and methods Patients treate
Autor:
Jonathan Wingate, David G. McLeod, Yongmei Chen, Stephen A. Brassell, Kevin R. Rice, Jennifer Cullen, Monica L. Colombo
Publikováno v:
International braz j urol v.37 n.5 2011
International Braz J Urol
Sociedade Brasileira de Urologia (SBU)
instacron:SBU
International braz j urol, Volume: 37, Issue: 5, Pages: 677-678, Published: OCT 2011
International Braz J Urol
Sociedade Brasileira de Urologia (SBU)
instacron:SBU
International braz j urol, Volume: 37, Issue: 5, Pages: 677-678, Published: OCT 2011
Objectives Prostate cancer (CaP) in the aging male will become an increasingly important and controversial health care issue. We evaluated the outcomes between a variety of treatments for low-risk CaP in patients 70 years of age and older. Methods an
Autor:
Shiv Srivastava, Philip Rosen, David G. McLeod, Stephen A. Brassell, Isabell A. Sesterhenn, Albert Dobi
Publikováno v:
Nature Reviews Urology. 9:131-137
Oncogenic activation of ERG resulting from gene fusion is present in over half of all patients with prostate cancer in Western countries. Although the underlying genetic mechanisms have been extensively studied, evaluation of the ERG oncoprotein--the
Autor:
Jennifer Cullen, David G. McLeod, Patrick M. Parker, Joseph R. Sterbis, Kevin R. Rice, Stephen A. Brassell, Yongmei Chen
Publikováno v:
Urology. 78:110-115
Objective To compare clinicopathologic features and survival outcomes for men 50 years of age in relation to other age groups stratified by race to further define prostate cancer (CaP) in young men. Controversy exists regarding the appropriate age to
Autor:
Stephen A. Brassell, Sally I. Elsamanoudi, Mario V. Da Rocha, Yongmei Chen, Emmanuel S. Antonarakis, David G. McLeod, Mario A. Eisenberger
Publikováno v:
BJU International. 108:378-385
OBJECTIVE To describe metastasis-free survival (MFS) and overall survival (OS) among men with prostate-specific antigen (PSA)-recurrent prostate cancer after radical prostatectomy who did not receive additional therapy until metastasis, using a multi
Autor:
Judith Travis, Robbin Lockhart, Stephen A. Brassell, Kevin R. Rice, Susan Houge, Jennifer Cullen, Libby Black, Jane Hudak, Kimberly Peay, Sally Elsamanoudi
Publikováno v:
Urology. 76:1231-1238
To identify racial and demographic factors that influence treatment choice and its resulting impact on health-related quality of life (HRQoL) for prostate cancer patients.Patients presenting to an equal access, military, multidisciplinary prostate ca